Shi, M.; Li, X.; Xing, L.; Li, Z.; Zhou, S.; Wang, Z.; Zou, X.; She, Y.; Zhao, R.; Qin, D.
Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease. Pharmaceutics 2024, 16, 1556.
https://doi.org/10.3390/pharmaceutics16121556
AMA Style
Shi M, Li X, Xing L, Li Z, Zhou S, Wang Z, Zou X, She Y, Zhao R, Qin D.
Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease. Pharmaceutics. 2024; 16(12):1556.
https://doi.org/10.3390/pharmaceutics16121556
Chicago/Turabian Style
Shi, Mingqin, Xinyao Li, Liwei Xing, Zhenmin Li, Sitong Zhou, Zihui Wang, Xuelian Zou, Yuqing She, Rong Zhao, and Dongdong Qin.
2024. "Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease" Pharmaceutics 16, no. 12: 1556.
https://doi.org/10.3390/pharmaceutics16121556
APA Style
Shi, M., Li, X., Xing, L., Li, Z., Zhou, S., Wang, Z., Zou, X., She, Y., Zhao, R., & Qin, D.
(2024). Polycystic Ovary Syndrome and the Potential for Nanomaterial-Based Drug Delivery in Therapy of This Disease. Pharmaceutics, 16(12), 1556.
https://doi.org/10.3390/pharmaceutics16121556
